Rapport Therapeutics, Inc. (RAPP) Insider Trading

Name: Rapport Therapeutics, Inc. (RAPP) insider trading: SEC Form 4 filings
Creator: Insiders Notifier
License: https://www.sec.gov/privacy#dissemination

Latest Form 4 (Oct 8, 2026): Abraham Ceesay (Chief Executive Officer): Sale of 3,375 shares, $108.1K.

Get alerted when insiders trade RAPP

Every alert includes an AI-written analysis of the filing, plus news and market context.

Email address

Loading company data...

Beta

Loading company details...

Beta